CytomX Therapeutics
Headquarters country
United States
Registry sponsor category
Industry
- Other names
- CytomX Therapeutics
- Company name
- CytomX Therapeutics
- Organisation type
- Industry
- Registered legal name
- CYTOMX THERAPEUTICS, INC.
- US industry code (SIC)
- Pharmaceutical preparations
- Registry sponsor category
- Industry
- SEC filer number (CIK)
- 0001501989
- Legal Entity Identifier (LEI)
- 5493004VW2FW0QLL3345
Related records
Trials (9)
- A Trial to Find Safe and Active Doses for an Investigational Drug, CX-904, for Patients With Advanced Solid Tumors
- First In Human Study of CX-2051 in Advanced Solid Tumors
- First In Human Study of CX-801 in Advanced Solid Tumors
- PROCLAIM-CX-072: A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas
- PROCLAIM-CX-188: A Trial to Find Safe and Active Doses of an Investigational Drug CX-188 for Patients With Solid Tumors
- PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors
- PROCLAIM-CX-2029: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2029 for Patients With Solid Tumors or DLBCL
- PROCLAIM: CX-072-002: Study of PD-L1 Probody Therapeutic CX-072 in Combination With Other Anticancer Therapy in Adults With Solid Tumors
- Study to Evaluate the Safety and Antitumor Activity of CX-2009 Monotherapy and in Combination With CX-072 in Advanced Breast Cancer